<i>ALK</i> Fusion in an Adolescent with Acute Myeloid Leukemia: A Case Report and Review of the Literature
Activating mutations and fusions of the <i>ALK</i> oncogene have been identified as drivers in a number of malignancies. Crizotinib and subsequent ALK tyrosine kinase inhibitors have improved treatment outcomes for these patients. In this paper, we discuss the case of an adolescent patie...
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
MDPI AG
2023-06-01
|
| Collection: | Biomedicines |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/2227-9059/11/7/1842 |